SUSQUEHANNA INTERNATIONAL GROUP, LLP - NOVELION THERAPEUTICS INC ownership

NOVELION THERAPEUTICS INC's ticker is NVLNF and the CUSIP is 67001K202. A total of 35 filers reported holding NOVELION THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 0.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
SUSQUEHANNA INTERNATIONAL GROUP, LLP ownership history of NOVELION THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$30,000
-67.0%
37,290
-64.6%
0.00%
Q4 2018$91,000
-73.2%
105,376
-8.2%
0.00%
Q3 2018$340,000
+211.9%
114,800
+266.8%
0.00%
Q1 2018$109,000
-41.7%
31,300
-47.8%
0.00%
Q4 2017$187,000
-20.8%
60,007
+172.8%
0.00%
Q1 2017$236,000
-77.7%
22,000
-82.5%
0.00%
Q4 2016$1,060,000125,9000.00%
Other shareholders
NOVELION THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,703,420$2,685,0002.61%
Healthcare Value Capital, LLC 1,400,000$1,015,0001.83%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 581,042$421,0000.06%
KNOTT DAVID M 109,135$79,0000.03%
EdgePoint Investment Group Inc. 3,100,931$2,248,0000.02%
Yakira Capital Management, Inc. 36,428$26,0000.01%
FRANKLIN STREET ADVISORS INC /NC 46,000$33,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 84,353$61,0000.00%
FARMERS & MERCHANTS INVESTMENTS INC 191$00.00%
MILLENNIUM MANAGEMENT LLC 19,814$14,0000.00%
View complete list of NOVELION THERAPEUTICS INC shareholders